About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, March 13th, 2018

The QualityStocks
Daily Stock List


CloudCommerce, Inc. (CLWD)

Wolf of Penny Stocks, MoneyTV, Epic Stock Picks, and Investor News Source reported earlier on CloudCommerce, Inc. (CLWD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CloudCommerce, Inc. is a provider of cloud commerce services to top brands. The Company is an international provider of cloud-driven e-commerce and mobile commerce solutions. In addition, CloudCommerce strategically acquires profitable cloud commerce solutions providers with strong management teams. The Company’s goal is to be a full-service provider of cloud commerce solutions for medium, large, and worldwide enterprises. CloudCommerce is based in Santa Barbara, California. The Company lists on the OTCQB.

CloudCommerce’s aim is to capitalize on the growth in technology industry subsets: Security Technology, Cloud Computing, Business Analytics, Storage, and Wireless, through acquiring strong companies in a roll-up strategy. The Company’s services include the development of highly customized and sophisticated online stores; real-time integration to other business systems; digital marketing and data analytics; complete and secure site management; and integration to physical stores.

CloudCommerce has its new digital marketing division. This new division will provide services that include Content Marketing, Marketing Automation, Social Media Strategy/Marketing, Search Marketing, Account-Based Marketing, Sales Enablement, Data Analytics, and Brand Strategy/Brand Experiences.

The Company’s plan is to expand into these areas of focus via direct sales efforts to existing clients, prospective clients and joint partnerships, and through the strategic acquisition of digital marketing services firms.

CloudCommerce acquired Indaba Group (Denver, Colorado). Indaba Group is a strategic e-Commerce agency. Indaba specializes in enterprise software development, e-Commerce platform development, creative services, and customer experience management

Indaba focuses on the Magento platform. The acquisition of Indaba Group brings a profitable and growing operation into CloudCommerce’s operations, which mesh well with the Company’s current e-Commerce development operations.

CloudCommerce acquired 100 percent of Parscale Creative, Inc. in 2017. Parscale Creative consists of certain assets spun out of Giles-Parscale, Inc., a San Antonio-based enterprise owned by Brad Parscale and Jill Giles.

After closing the transaction, Parscale Creative was renamed Parscale Digital, Inc. Parscale is a fast-growing provider of enterprise digital marketing services.

CloudCommerce announced in November 2017 that it acquired 100 percent of WebTegrity, Inc. WebTegrity is a provider of enterprise digital marketing services. WebTegrity is based in San Antonio, Texas. It serves clients including Generations Federal Credit Union, University Health System, UTSA, Petco Foundation, and Animal Defense League.

In December 2017, CloudCommerce said that the filing of its first quarterly report after its acquisition of Parscale Creative (renamed Parscale Digital), shows growth in consolidated revenue of 118 percent over the prior year-over-year quarter.

Total Revenue for the three months ended September 30, 2017 grew by $1,294,325 to $2,386,999, versus $1,092,674 for the three months ended September 30, 2016. The growth in Revenue was mainly due to adding two months results from the acquisition of Parscale Digital, acquired on August 1, 2017.

In January of this year, CloudCommerce announced that it filed an 8-K changing the Company’s fiscal year end from June 30 to December 31, effective immediately. Because of this change, CloudCommerce will file a Transition Report on Form 10-K for the six-month period ended December 31, 2017.

The Company now expects that 2018 revenue will be about $11.5 million. It is basing this on its trending sales performance, underlying strength of the core business, and projected growth from new services.

CloudCommerce, Inc. (CLWD), closed Tuesday's trading session at $0.0255, down 15.00%, down 49,582 volume with 9 trades. The average volume for the last 60 days is 53,940 and the stock's 52-week low/high is $0.0051/$0.0625.

Agritek Holdings, Inc. (AGTK)

CFN Media Group, Promotion Stock Secrets, PennyPro, SmallCapVoice, and Cannabis Financial Network News reported on Agritek Holdings, Inc. (AGTK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Agritek Holdings, Inc. is a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector. It provides unique technology and agricultural solutions for the medicinal and recreational cannabis industry. Agritek Holdings is headquartered in Miami, Florida. The Company has a satellite office in San Juan, Puerto Rico.

Agritek Holdings does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene U.S. law or the Controlled Substances Act. It does not intend to do so in the future.

The Company owns property in Colorado approved for cultivation, and manufacturing capabilities by way of California partnerships. Also, it owns a number of Hemp and cannabis brands for distribution.

Agritek’s solution is an integrated platform designed for commercialization in three high-value segments of the global cannabis market – Real Estate, AGTK Brands/IP, and Infrastructure. The Company’s brands are a premium positioned set of consumer brands for medical wellness and recreational use. Agritek owns several hemp and cannabis brands for distribution. These include MD Vapes, MicroDose Strips, and "Hemp Pops" and "California Premiums.

The Company’s Colorado property is 80-Acres approved for cannabis cultivation or manufacturing facility in Pueblo, Colorado. Its Puerto Rico property is a 25,000-sq. ft. licensed cannabis cultivation and manufacturing facility.

Agritek’s Canada property is a cannabis friendly "Bud & Breakfast" concept. It is one hour from Quebec City, Quebec. It is on 15-acres that includes nine guest rooms plus a separate detached grow facility.

Regarding Agritek’s new state-of-the-art, San Juan-based facility, it contains 15,000 usable square feet that will be the first vertically integrated cannabis operation in San Juan, Puerto Rico that will operate as a cultivation and manufacturing facility, and also a separate space that can be dedicated to a retail dispensary partner.

Last month, Agritek Holdings announced that it ended its quarter with the first revenues from Hemp CBD sales via its California operations. B. Michael Friedman, Agritek Holdings’ Chief Executive Officer, stated, " We are beginning to see first revenue streams from our new brands focused within the Hemp and CBD markets in Colorado and California. Our unique product lines for the Hemp CBD market place within California and Colorado include our MD Oral Strips, MD Vape lines with multiple flavored terpenes, and our new Hemp Pops, which contain a 25 mg dose within a lollipop in six flavors.”

Furthermore, in February, Agritek Holdings announced that it has expanded manufacturing of the exclusive licensed “California Premiums” pre-roll brand to a licensed Pre-ICO manufacturing facility in Los Angeles, California. This new manufacturing facility will permit Agritek to straight away boost production of the California Premiums Brand to meet demand and requests by local dispensaries in West Hollywood and delivery services for the product.

Last week, Agritek Holdings announced that it received its first purchase order for 10,000 MD Vape cartridges from a licensed California based facility. Agritek will be the exclusive provider for cartridges and provide filling machines for the new private labeled line to be sold exclusively within the California recreational market. Agritek Holdings will receive royalties on the private labeled brand via its MD Vapes division separate and apart from the cartridge, vaporizer batteries, and filling machine purchase orders.

Agritek Holdings, Inc. (AGTK), closed Tuesday's trading session at $0.01675, down 6.69%, down 2,727,628 volume with 125 trades. The average volume for the last 60 days is 12,211,614 and the stock's 52-week low/high is $0.0094/$0.0545.

CurAegis Technologies, Inc. (CRGS)

InvestorsHub and OTC Markets reported on CurAegis Technologies, Inc. (CRGS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CurAegis Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division. CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. CurAegis Technologies is based in Rochester, New York.

The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. The Company completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. It earlier said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The CURA System comprises hardware and software that measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels.

The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.

Pertaining to the Aegis Division’s Aegis Pump and Motor, it has eliminated the rotating piston group (the cylinders are stationary). This makes the pump very strong and easy to manufacture. The Company’s patented valving has been integrated to boost efficiencies at peak and off peak operation.

In September of 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The first of six Z-Coach e-learning modules, Z-Coach Aviation, was designed for aviation professionals.

If the CURA (Circadian User Risk Assessment) software detects an issue, Z-Coach creates a back-end solution required to induce change and improve behavior. This program is broken down into two parts: Z-Coach Education and Z-Coach Intervention.

Regarding the CURA System, it now works with iOS and Android phones. The Company has aligned the communications between its watch, the smart phone and its cloud.

The CURA System will make an individual aware of the importance of sleep in their daily life. It will show one how to easily change their behavior to make their life safer, healthier, and longer. Moreover, it gives a person accurate and relevant real-time information concerning their present and long-term sleep and fatigue health.

CurAegis Technologies is on schedule to have the technology for its MyCadian and other wearable products ready for sales and delivery in late March or early April 2018. The Company’s objectives are to make its axial piston hydraulic pumps and/or motors smaller, more efficient and considerably less costly to produce. CurAegis is expecting to have its initial pre-production prototype ready by the end of next month. The Company has tested and proven out a good portion of its technology’s goals.

CurAegis Technologies’ plan is to license its technology to major manufacturers. It may consider an exclusive licensing agreement for a period of time if it believes that it is the best way to reach original equipment manufacturer (OEM) and after-market customers.

CurAegis Technologies, Inc. (CRGS), closed Tuesday's trading session at $0.409, up 34.10%, on 9,900 volume with 5 trades. The average volume for the last 60 days is 16,959 and the stock's 52-week low/high is $0.246/$1.49.

Medicine Man Technologies, Inc. (MDCL)

CFN Media Group, The Street, MarketWatch, Marketwired, and Stockhouse reported on Medicine Man Technologies, Inc. (MDCL), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Medicine Man Technologies, Inc. represents and licenses the cultivation and dispensary Intellectual Property (IP) of Medicine Man - a well-respected Tier III operator in Colorado. Medicine Man Technologies provides cultivation consulting services for cannabis growing technologies and methodologies. The Company is one of the nation’s foremost cannabis brand development and consulting enterprises. Established in 2014, Medicine Man is based in Denver, Colorado. The Company lists on the OTCQB.

Medicine Man works closely with industry-leading extraction partners. These partners provide the required licensing service support and formulations to help customers with their planned deployment of a successful processing facility.

At present, Medicine Man Technologies has 63 active clients in California, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, Massachusetts, Puerto Rico, Australia, Canada, Germany, and South Africa.

The Company is concentrating on working with clients to use its experience, technology, and training to help secure a license in states with newly emerging regulations. In addition, it is centering on deploying its highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminating the liability of single grower dependence.

Medicine Man is also continuing the expansion of its Brands Warehouse concept. Also, the Company engages in retail operations of cannabis products. It additionally provides general business and referral management for other related service providers for its customers. It cultivates and sells through its parent company Medicine Man Denver, the largest cultivation/retail facility in the State of Colorado.

Medicine Man’s risk-averse cannabis cultivation technology delivers consistent, high quality, high yield production within a clean-room style environment. The Company’s state-of-the art dispensary model ensures patients and consumers have safe and secure access to a variety of medical and/or recreational cannabis products.

Earlier, Medicine Man Technologies announced that the definitive agreement to acquire Denver Consulting Group, LLC was executed by the parties on July 21, 2017. The acquisition became effective on July 24th upon the filing of applicable documents with the Colorado Secretary of State. Denver Consulting Group has offices in Denver, Colorado, and Portland, Oregon.

Medicine Man Technologies has recently added two new clients. The Company now has cultivation projects representing just over 700,000 gross square feet of California based project space. These projects represent numerous clients, some of which are considering stacking of the 10,000-square foot license type (small indoor) as presently expected to be allowable under the initial draft regulations recently released.

Medicine Man Technologies, Inc. (MDCL), closed Tuesday's trading session at $1.95, up 0.52%, on 26,959 volume with 34 trades. The average volume for the last 60 days is 76,879 and the stock's 52-week low/high is $0.92/$3.40.

Spotlight Innovation, Inc. (STLT)

Penny Picks, PennyStockScholar, Journal Transcript, PennyStockLocks.com, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to innovative and proprietary platform technology candidates. Its focus is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.

The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. OTCQB-listed, Spotlight Innovation has its corporate headquarters in Urbandale, Iowa.

Spotlight’s mission is to significantly impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is realized by way of its extensive relationships with many top academic institutions and other sources. The Company provides value-added development capability and funding to hasten development progress.

Spotlight works to acquire the rights, through acquisition, license, or otherwise, to unique and proprietary Platform Technology Candidates. Furthermore, it works to provide value-added development capability and funding to realize quick IND approval to start human clinicals for targeted Platform Technology Candidates.

The Company provides solutions for healthcare-centered companies commercializing healthcare intellectual property (IP). Spotlight Innovation will partner with proven market leaders via sale, out-license, or strategic alliance, when commercially significant benchmarks have been attained.

The Company has obtained from the Florida State University Research Foundation (FSURF) exclusive international rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.

Moreover, Venodol Roll-on is a new chronic pain relief product from Spotlight Innovation subsidiary Caretta Therapeutics. The product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.

Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. The Company’s subsidiary, Celtic Biotech, commenced Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. ImmunoClin Ltd. is the contract research organization (CRO) supervising the study conduct.

Today, Spotlight Innovation announced that U.S. Patent No. 9,895,358 entitled Combination Therapies for Treatment of Spinal Muscular Atrophy was issued to Indiana University Research and Technology Corp. and The Brigham and Women’s Hospital, Inc. This patent discloses compositions and methods for the treatment of spinal muscular atrophy (SMA), including STL-182 and related compounds, to which Spotlight holds an exclusive, global commercial license.

Spotlight Innovation, Inc. (STLT), closed Tuesday's trading session at $0.10, down 18.70%, on 5,300 volume with 3 trades. The average volume for the last 60 days is 16,895 and the stock's 52-week low/high is $0.065/$0.58.

TechPrecision Corp. (TPCS)

Stock Rich, Marketbeat, TopPennyStockMovers, Zacks, StreetInsider, Energy and Capital, Wealth Daily, FeedBlitz, SmallCapVoice, BullRally, HotOTC, CoolPennyStocks, PennyStockVille, MadPennyStocks, and Stock Market News Alert reported beforehand on TechPrecision Corp. (TPCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TechPrecision Corp., through its wholly-owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., is an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems. The Company’s goal is to be an end-to-end international service provider to its customers through furnishing customized and integrated turn-key solutions for completed products necessitating custom fabrication and machining, assembly, inspection, and testing.

OTCQB-listed, TechPrecision has its head office in Westminster, Massachusetts. The Company’s subsidiary companies have facilities in the U.S. and China. TechPrecision’s products are used in the alternative energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others.

The Company has the fabrication capacity to see a client’s large-scale components through from initial processing to final finishing and assembly. This eliminates the need for outside servicing. In addition, it helps ensure lower costs.

TechPrecision’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Clean Technology, Energy, Medical, Aerospace, and Defense sectors. Ranor’s capabilities encompass Production Control; Engineering; Processing; Fabrication; Machining; Assembly & Finishing; Quality Assurance, and NDE & Inspection.

The design of TechPrecision’s Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the growing global demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region's wind power and solar challenges.

CMC utilizes one of the largest forges in the industry. CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance. CMC serves the Solar/LED; Wind; Nuclear; Clean Technology, Medical; and General Industrial industries.

In February, TechPrecision reported financial results for Q3 and the nine months ended December 31, 2017. Net Sales for the three months ended December 31, 2017 were $3.6 million. This represents a 32 percent decrease versus the same quarter a year prior.

Net Sales for the nine months ended December 31, 2017 were $14.1 million. This represents a 3 percent increase versus the same period a year prior. The Company’s Sales order backlog at December 31, 2017 was $11.2 million versus a backlog of $15.8 million at March 31, 2017.

Mr. Alexander Shen, Chief Executive Officer of TechPrecision, said, "Our third quarter results were impacted by two factors: first, defense customer appropriations and funding delays resulted in lower order volume, and second, a higher mix of lower margin shipments. We expect a strong pipeline of business ahead, once the appropriations and funding delays are resolved. As of today, we have in place certain agreements which release funding for materials acquisition in advance of new orders to build components for a number of our key customers."

TechPrecision Corp. (TPCS), closed Tuesday's trading session at $0.51, even for the day, on 37,294 volume with 20 trades. The average volume for the last 60 days is 51,729 and the stock's 52-week low/high is $0.4602/$0.80.

QS Energy, Inc. (QSEP)

Equity Clock, Stockhouse, MarketWatch, RedChip, InvestorsHub, Stockopedia, Marketwired, StockInvest.us, The Street, and Small Cap Exclusive reported earlier on QS Energy, Inc. (QSEP), and we report on the Company today, here at the QualityStocks Daily Newsletter.

QS Energy, Inc. is a developer of integrated technology solutions for the energy industry. It develops and commercializes energy efficiency technologies that help in meeting increasing global energy demands, improving the economics of oil extraction and transport, and lessening greenhouse gas emissions. QS Energy’s Intellectual Property (IP) portfolio includes 48 domestic and worldwide patents and patents pending. These have undergone development in combination with, and exclusively licensed from, Temple University. OTCQB-listed, QS Energy is headquartered in Tomball, Texas.

The Company’s AOT™ (Applied Oil Technology) is a group of commercial crude oil pipeline flow assurance products designed to undergo installation at pipeline pump stations in the upstream, gathering, and midstream sectors. AOT™ is an integrated system. It improves critical operational efficiencies for pipeline operators globally.

AOT™ is an industrial hardware system. It is completely fabricated in the U.S. AOT™ lowers the viscosity of unrefined oil utilizing low wattage electrical fields (electrorheology) to improve flow while in transit via pipelines.

AOT™ technology delivers performance that can be measured in each of the areas of importance in the movement hydrocarbon stream - from reservoir to the point of sale. QS Energy’s AOT™ stand-alone or supplemental pipeline solutions increase flow rates; reduce power consumption; optimize flow assurance; enhance pipeline integrity; and prevent bottlenecks.

QS Energy has its new strategic plan. The core mission of this plan is to hasten market adoption of its AOT™ technology. The Company is now positioned to complete its development from research and development (R&D) to commercialization. All through last year, it worked to improve the efficacy and efficiency of its AOT technology, executing a retrofit program underpinned by lessons learned while operating its equipment on midstream pipelines under commercial operating conditions.

Recently, QS Energy has been working diligently on the installation and operation of one or more pilot projects. The Company’s efforts to secure one or more pilot projects are now centered on specific prospects in three primary markets. These are the United States South America, and Asia. Each of these prospects operates heavy crude oil pipelines with an identified system-wide need likely to benefit AOT viscosity reduction.

QS Energy, Inc. (QSEP), closed Tuesday's trading session at $0.1105, up 10.50%, on 38,201 volume with 13 trades. The average volume for the last 60 days is 69,810 and the stock's 52-week low/high is $0.0501/$0.32.

AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, CFN Media Group, Promotion Stock Secrets, and SmallCapVoice reported earlier on AXIM Biotechnologies, Inc. (AXIM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company focusing on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The Company discovers and brings to market innovative solutions via research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. is a major investor in AXIM. AXIM Biotechnologies is headquartered in New York, New York.

The Company’s emphasis is on unique proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is presently no effective treatment. AXIM is advancing its patented controlled-release cannabinoid gum in studies encompassing a number of indications. AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants.

AXIM’s pipeline of Intellectual Property (IP) protected cannabinoid-based products additionally include MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. This pioneering invention is on course to be fully registered by the EMA and the Food and Drug Administration (FDA) by the end of 2017. It is the world’s first patented cannabinoid controlled-release chewing gum.

In addition, AXIM’s products include RENECANN™ - the world’s first cannabigerol (CBG)-based skincare product line. Moreover, its products include ORAXIMAX™ - the world’s first CBG-based oral care product line; Suppocann™ - a suppository cannabinoid-release product for GI conditions including IBD, IBS and Crohn’s disease; and Ophthocann™ and Cannbleph™ - cannabinoid-based products for the reducing of intraocular pressure and for the relief of conjunctivitis.

The Company’s IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in different stages of approval.

In November, AXIM® Biotechnologies announced clinical trial results from its first Phase II pilot trial for the treatment of irritable bowel syndrome (IBS) with its CanChew +® CBD (cannabidiol) functional, controlled release chewing gum. The study was conducted at Wageningen University in The Netherlands. It was a randomized, placebo controlled, double-blind, cross-over trial aimed at investigating acceptance and overall pain reduction.

Study results indicate that CanChew+® was well tolerated by the IBS patients. In addition, no significant adverse side effects were observed by any participants of the trial. All patients who participated in the study experienced decrease in their levels of pain score.

Earlier this month, AXIM® Biotechnologies announced that it successfully completed a pre-investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for a dronabinol-based functional, controlled-release chewing gum product the Company is developing to help treat patients with chemotherapy-induced nausea and vomiting and HIV/AIDS patients experiencing appetite and weight loss. AXIM will now start preparing its IND filing to the FDA for this new chewing gum product, referencing Marinol®, one of the FDA-approved, dronabinol-based drugs available in the United States.

AXIM Biotechnologies, Inc. (AXIM), closed Tuesday's trading session at $5.12, up 0.39%, on 33,766 volume with 44 trades. The average volume for the last 60 days is 36,293 and the stock's 52-week low/high is $4.45/$16.245.

Osprey Gold Development Ltd. (OSSPF)

Stockhouse, InvestorsHub, Morningstar, WatchDog Stocks, MarketWatch, 4-Traders, OTC Markets, Junior Mining Network, Investing News, and Stock Orange reported on Osprey Gold Development Ltd. (OSSPF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Osprey Gold Development Ltd. concentrates on exploring five historically producing gold properties in the Province of Nova Scotia. The Company’s flagship project is Goldenville, in the historical mining district Goldenville, which is one of eastern Canada’s most significant gold belts. Osprey Gold has the option to earn 100 percent (subject to certain royalties) in all five properties. This includes the Goldenville Gold Project. Osprey Gold Development is based in Vancouver, British Columbia.

The Goldenville Gold Project is in Guysborough County, Nova Scotia. It was the subject of the recently completed 3,044 meter (m) diamond drill program. This Project recorded more than 212,300 ounces of gold production between 1862 and 1942.

Goldenville has an updated NI 43-101 inferred resource, which includes 2,800,000 tonnes at 3.20 g/t gold for a total of 288,000 ounces of gold (2.8 mil tonnes at 4.96 g/t gold for 447,000 ounces of gold uncapped).

In addition, Osprey Gold is exploring the past producing Caribou, Lower Seal Harbour, Miller Lake, and Gold Lake gold projects. It entered into a definitive agreement whereby it has acquired an option to acquire the Caribou Gold Property from John Logan Enterprises Ltd. With this Option Agreement, Osprey Gold may acquire a 100 percent interest (subject to certain royalties) in 16 contiguous mining claims (256 hectares) hosting the past-producing Caribou Property. The Caribou Gold contains an historic gold deposit that was intermittently mined between 1869 and 1955.

The Lower Seal Harbour project is in Guysborough County, Nova Scotia. The property is approximately 35 kilometers from Goldenville. Gold at Lower Seal Harbour is found in the veins and the host rocks.

The Miller Lake Project is about 14 kilometers from Goldenville. It has historic production and limited recent exploration. The Gold Lake Project is roughly 70 kilometers northeast of Halifax. It was discovered in 1867 with minor production taking place in the late 1800’s.

Last month, Osprey Gold announced additional assay results from its 18 hole, 3,044 meter (m) drill program at its Goldenville Property. Of note in the 2017 holes are numerous significant intercepts reflecting the mineralized nature of the Goldenville trend where gold is hosted in an assortment of stacked quartz veins and host rocks within a large anticlinal fold.

Osprey Gold Development President, Mr. Cooper Quinn, said, "We're very happy with the results of this program. These results support the potential to expand our current resource at Goldenville. The drill program also tested for broader zones of mineralization outside of the vein-hosted gold; this was successful in the southern limb of the Goldenville anticline in hole G17-14 which contained multiple intercepts of lower grade mineralization within the host rock. In the northern limb, results in the Bluenose Mine shaft area are very encouraging, returning the highest grades Osprey has drilled to date as well as broad zones of mineralized host rock and quartz veining, highlighted in hole G17-15 drilled over 300 m along strike to the east from G17-14."

At the beginning of March, the Company announced assay results from three holes drilled on the western portion of the Goldenville property in the Mitchell Lake Zone. The release includes results for three holes totaling 435 m. All three holes hit numerous intervals of gold mineralization, characterized by high grade quartz vein hosted gold and broad lower grade gold intercepts with mineralized host rock and veinlets.

Osprey Gold Development Ltd. (OSSPF), closed Tuesday's trading session at $0.0607, down 20.13%, down 62,500 volume with 6 trades. The average volume for the last 60 days is 31,813 and the stock's 52-week low/high is $0.0601/$0.34.

Margaux Resources Ltd. (MARFF)

Equities, 4-Traders, MarketWatch, Stockhouse, and OTC Markets reported on Margaux Resources Ltd. (MARFF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Margaux Resources Ltd. is a mineral acquisition and exploration company headquartered in Calgary, Alberta. The Company’s emphasis is on zinc, gold and tungsten resources in the richly mineralized Kootenay Arc region of southeastern British Columbia. These include the Jersey-Emerald, Sheep Creek, and Bayonne, Jackpot, Canex, Ore Hill and AspenEx properties. Margaux Resources’ shares trade on the OTC Markets’ OTCQB.

On the basis of historic production, Margaux Resources’ Jersey-Emerald property is the third largest zinc-lead producer in British Columbia, and also the second largest tungsten producer in North America. The Company’s close by Sheep Creek property has historic gold production totaling 690,000 ounces, from 26 historic gold vein mines. It is analogous to the Barkerville District of central British Columbia.

The Jersey-Emerald property is a zinc-lead, tungsten + gold project, acquired in 2014. The Jackpot property is a zinc, lead + silver property, acquired in 2016. The Bayonne & Sheep Creek gold + silver properties were acquired in January 2017. The Ore Hill & AspenEx gold, silver + zinc-lead properties were acquired in March 2017.

Margaux Resources has a large land position: 22,353 ha (55,235 acres) of claims. The Company has extensive historic data on all properties. In addition, it has near-term cash flow potential from historic tailings.

The above-mentioned Kootenay Arc region is a massive past producer of gold, zinc & tungsten. There has been little lead-zinc mining activity since the 1970/80s and gold activity since the 1940s. It is here that Margaux Resources has amassed 22,353 hectares of high quality mineral, crown & placer claims. The Company’s assets lie within the Kootenay Arc. The zinc-lead-silver belt extends 300 kilometers.

In 2017, Margaux Resources conducted its exploration program, including Diamond Drilling: Sheep Creek & Bayonne (Gold) and Jackpot (Zinc). The Company has its Sheep Creek NI 43-101 Report.

The Company’s assets are located in a prolific and mining friendly district near the historic town of Salmo, where Margaux has established a fully operational office. Margaux Resources has a pipeline of projects with Greenfield and Brownfield potential with premier infrastructure situated 45 kilometers from a zinc-lead smelter.

Recently, Margaux Resources announced that it acquired additional claims to expand its Kootenay Arc project holdings in southeastern British Columbia. Furthermore, Margaux received high-grade gold grab sample results from the Sheep Creek and Bayonne properties.

Highlights include 1,670 hectares of newly acquired mineral claims; orogenic gold mineralization favorable area; a high-grade gold sample at Sheep Creek including up to 15.5 g/t Au; a 13.0 g/t Au grab sample returned from Bayonne; as well as a new vein discovered at Bayonne.

Margaux Resources Ltd. (MARFF), closed Tuesday's trading session at $0.2159, up 6.51%, on 700 volume with 2 trades. The average volume for the last 60 days is 1,046 and the stock's 52-week low/high is $0.1581/$0.267.


The QualityStocks
Company Corner


PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.3681, up 6.67%, on 63,748 volume with 40 trades. The stock’s average daily volume over the past 60 days is 17,926, and its 52-week low/high is $0.01/$0.80.

Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P) and PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today announced the grant of three permits by the Australian Government, Department of Health, for the importation of cannabis into Australia for research purposes.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Grant of Australian Cannabis Importation Permits

CannabisNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Proprietary Sol-gel Formulations May Significantly Improve Bioavailability

NetworkNewsAudio Announces Audio Press Release (APR) on PreveCeutical Medical Inc.'s Focus on Gene Therapy Treatments

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.1126, up 6.53%, on 394,244 volume with 40 trades. The stock’s average daily volume over the past 60 days is 464,553, and its 52-week low/high is $0.0045/$0.52.

Among the new financial buzzwords added to Merriam-Webster’s famous dictionary website are ‘blockchain’ and ‘cryptocurrency’, proving that this latest high-tech terminology has quickly gone mainstream (http://nnw.fm/fKII2). Epazz, Inc. (OTC: EPAZ), a leading provider of cloud-based software solutions and blockchain mobile apps – including its ZenaPay cryptocurrency wallet app – is successfully developing several cutting-edge technologies that allow consumers to acquire digital currencies, both online and at the point-of-sale.

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz, Inc. (EPAZ) Challenges Status Quo with ZenaPay Cryptocurrency Wallet

NetworkNewsBreaks – Epazz, Inc. (EPAZ) Further Expands Portfolio of Blockchain Apps with Bitcoin Altcoins Tracker

Epazz, Inc. (EPAZ) Featured on 3/9 Episode of MoneyTV with Donald Baillargeon

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.01755, off by 0.85%, on 7,806,682 volume with 173 trades. The stock’s average daily volume over the past 60 days is 12,146,432, and its 52-week low/high is $0.0141/$0.16.

Global Payout Inc. (OTCPink:GOHE) is pleased to announce that its subsidiary MoneyTrac Technology, Inc. ("MTRAC", the "Company") will join its partner, GreenBox POS ("GBOX") at the Cal-Israel Expo in Tijuana on March 20th and 21st.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Breaking Boundaries: MTRAC partner GreenBox Will Attend Cali-Baja Israel Mexico Innovation Expo in Tijuana

Global Payout Inc. (GOHE) has Many Fingers in the Fintech Pie

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Launches MTRAC-Token™ to Combat Payment Restrictions in the Cannabis Market

IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH). Today, IEG Holdings Corp. closed trading at $0.2625, up 0.08%, on 121 volume with 1 trade. The stock’s average daily volume over the past 60 days is 97,901 and its 52-week low/high is $0.14/$4.19.

In a January 2018 report, ACF Equity Research projected that IEG Holdings Corp. (OTCQB: IEGH) revenues will essentially quadruple over the next couple years and the company will maintain positive EBITDA (http://nnw.fm/i9LkJ). Serving the large underbanked population in the United States, IEG Holdings provides unsecured, five-year consumer loans of $5,000 and $10,000 under the brand name ‘Mr. Amazing Loans’ through its website (www.MrAmazingLoans.com).

IEG Holdings Corp. (IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand "Mr. Amazing Loans." Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company's Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company's loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans's terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer's checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH's other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings' chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young's 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting. Disclaimer

IEG Holdings Corp. Blog

IEG Holdings Corp. News:

IEG Holdings Corp. (IEGH) Revenues Pegged to Quadruple by 2020

IEG Holdings Corp. (IEGH) Creates Crypto Excitement in the Loan Industry

IEG Holdings Corp. (IEGH) Projected to Reach $5.3M in Revenue in FY2019 by Equity Research Firm

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0609, up 1.50%, on 2,724,009 volume with 232 trades. The stock’s average daily volume over the past 60 days is 9,295,421, and its 52-week low/high is $0.0132/$0.415.

NetworkNewsWire, a multifaceted financial news and publishing company for business, today announces the audio version of SinglePoint, Inc.’s (OTCQB:SING) recent press release: “SinglePoint Launches Cannabis Payment Solution and Provides Shareholder Update.” To hear the SinglePoint AudioPressRelease (APR) version, visit: http://nnw.fm/pY0Ks. To read the original press release, visit: http://nnw.fm/T8fpU.

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Inc.’s (SING) Launch of Cannabis Payment Solution Covered by NetworkNewsAudio

SinglePoint Inc.’s (SING) Zero-Waste Cannabis Division Program Covered by NetworkNewsAudio

CannabisNewsBreaks – SinglePoint, Inc. (SING) Updates Shareholders with Third Episode of Video Series

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.39, off by 0.71%, on 97,678 volume with 190 trades. The stock’s average daily volume over the past 60 days is 351,403 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, is pleased to announce it has completed the world's first study evaluating DehydraTECHTM used in a topical cream formulation for absorption of cannabidiol ("CBD") through human skin. Results proved significant increases in both speed and quantity of CBD absorption through skin when compared to control formulations.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. Completes Successful Skin Absorption Study

Chris Bunka, CEO of Lexaria Bioscience Corp., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Discuss New Products and Company Evolution

NetworkNewsAudio Announces an Audio Press Release (APR) on Lexaria Bioscience Corp. and its Potential Disruption in Nicotine Delivery

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.397, off by 5.48%, on 4,988,843 volume with 1,116 trades. The stock’s average daily volume over the past 60 days is 14,552,090, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding Inc. (OTC Pink:POTN) (“Company”), announced today that after considerable evaluation and planning, the Company enters into the rapidly growing global blockchain crypto technology sector through strategized investments that it is making through its new wholly-owned subsidiary, Blockchain Crypto Technology Corp. 

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding To Enter World’s Fastest Growing Market With Formation Of Blockchain Crypto Technology Subsidiary

PotNetwork Holding Unveils New Products At World’s Premiere Trade Show, ASD Market Week

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Featured in Comprehensive Research Report by Harbinger Research, LLC

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $1.06, off by 5.36%, on 19,174 volume with 20 trades. The stock’s average daily volume over the past 60 days is 134,815 and its 52-week low/high is $0.20/$1.75.

ORHub, Inc. (OTC:ORHB), an advanced physician-driven digital software company focused on improving profitability and the cost effectiveness of hospitals through real-time smart data and analytics, today announces that Ray Oliver is joining ORHub as its Senior Vice President of Operations responsible for the expansion of customer success, implementation, sales and support organizations.  

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub Announces New Senior Vice President of Operations

SinglePoint Launches Cannabis Payment Solution and Provides Shareholder Update

Blockchain Innovations Set to Disrupt Healthcare

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.4434, off by 6.88%, on 463,747 volume with 586 trades. The stock’s average daily volume over the past 60 days is 103,736, and its 52-week low/high is $0.015/$1.8892.

Petroteq Energy Inc. (TSXV: PQE; OTCQX: PQEFF; Frankfurt: A2DYWC), a company focused on the development and implementation of proprietary technologies for the energy industry, today announced components and features of its proposed blockchain based oil & gas supply management platform.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq's PetroBLOQ Announces Capabilities of Blockchain Based Oil & Gas Supply Chain Management Platform

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Deploys Patented Oil Sands Extraction Technology to Expand Production Capacity

Petroteq's PetroBLOQ Blockchain Subsidiary Opens Development Facility In Southern California

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.12875, off by 9.78%, on 32,184 volume with 12 trades. The stock’s average daily volume over the past 60 days is 72,638, and its 52-week low/high is $0.0519/$0.325.

Reign Sapphire Corp. (OTCQB: RGNP), a direct-to-consumer, custom and branded jewelry company, is pleased to provide an update on one of its four core business units, as well as the performance of its revamped marketing strategy and expectations for 2018.

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

Reign Sapphire Corp. Provides Update on Core Business Unit, Discusses Revenue Strategy

Report: Exploring Fundamental Drivers Behind Spindle and Reign Sapphire - New Horizons, Emerging Trends, and Upcoming Developments

Reign Sapphire Corp. (RGNP) – Custom Jewelry for Millennials


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(SPEX) +54.62%


(PTI) +54.11%


(STGZ) +47.27%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251